Mobile app to help manage type 1 diabetes insulin doses
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests a mobile app that helps you adjust your insulin doses. It is for people with type 1 diabetes who have high blood sugar levels and are already taking multiple daily insulin injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 15 years old.
- You must have type 1 diabetes with an HbA1c of 7% or higher (uncontrolled blood sugar).
- You must be using multiple daily insulin injections for at least 3 months.
- You must be willing to check your blood sugar at least 3 times a day during the study.
- You cannot be pregnant or planning to become pregnant.
- You should not have conditions that raise your risk of severe low blood sugar (like heart disease or hypoglycemia unawareness).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smartphone app that helps people with type 1 diabetes predict their blood sugar and decide how much insulin to take. It may be a good fit if you already use multiple daily insulin injections and a continuous glucose monitor.
This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.
This trial tests whether a structured educational program delivered through a mobile app can help teens with type 1 diabetes improve their blood sugar control (HbA1c), feel more confident managing their condition, and take better care of themselves.
This study tests a mobile app to help people with type 2 diabetes manage their blood sugar better. It might be a good fit if your blood sugar has been running high and you're ready to use your smartphone to track your health.
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
This trial tests the EkiYou smartphone app to help calculate your mealtime insulin dose. You need to have diabetes, use both a long-acting and a short-acting insulin pen, and be comfortable with a CGM and a smartphone.
Hear when a new Type One Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.